sur Zomedica Corp. (NASDAQ:ZOM)
USEA Names Zomedica’s PulseVet as Official Shock Wave Provider for 2024
ANN ARBOR, MI / ACCESSWIRE / July 17, 2024 – Zomedica Corp. (NYSE American: ZOM) announced that the United States Eventing Association, Inc. (USEA) has designated PulseVet as the "Official Shock Wave of the USEA" for 2024. As part of this collaboration, PulseVet will be a "Gold Sponsor" of the USEA American Eventing Championships, "Bronze Sponsor" of the USEA Classic Series, and "Contributing Sponsor" for various other events.
Zomedica’s PulseVet system uses electro-hydraulic shock wave technology to treat conditions such as tendon and ligament injuries, osteoarthritis, chronic pain, and wound healing in equine, canine, and feline patients. This technology promotes cell stimulation and the release of growth factors, which aid in reducing inflammation and accelerating healing.
CEO Larry Heaton expressed enthusiasm about the partnership, emphasizing the company's commitment to enhancing veterinary care. USEA CEO Rob Burk and Zomedica’s Senior Product Manager Courtney Calnan echoed similar sentiments, highlighting the positive impact on equine health.
PulseVet's shock wave technology has been extensively researched and shown effective in addressing various veterinary conditions. The market for PulseVet devices in the US is estimated to be around $1 billion, with additional recurring revenue from consumables.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Zomedica Corp.